Hepatitis (DBCOND0013077)

Identifiers

Synonyms
Inflammatory liver disease, unspecified / Liver inflammation / Inflammatory disease of liver (disorder) / Hepatitis, unspecified / Hepatitis nonspecific / Nonspecific hepatitis / Hepatitis NOS

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Pyridoxine
A vitamin used to correct vitamin B6 deficiency and to treat nausea during pregnancy.
Sodium bisulfite
An ingredient in parenteral nutrition products for patients with severe liver disorders.
No drug targets
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT03089983
Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settingshealth_services_researchNot Availablecompleted
NCT01062321
Role of Cytokines in Hepatitis E Virus Infection During PregnancyNo drug interventionsNot AvailableNot Availablecompleted
NCT02342821
Empowering Immigrants in the Greater Boston Area to Connect to HBV CareNo drug interventionsNot AvailableNot Availableunknown_status
NCT03166943
the Possible Effect of the Antiviral Inhibitors for Treatment of Hepatitis C Virus Infection in Cardiac FunctionNo drug interventionsdiagnosticNot Availableunknown_status
NCT01889433
An Open-label Comparative Efficacy and Safety Study of Algeron (Cepeginterferon Alfa-2b) in Treatment-naive Patients With Chronic Hepatitis Ctreatment3completed
NCT01645033
Computer-based Cognitive Behavioral Therapy for Risky Behaviors in Opioid Dependent PatientsNo drug interventionstreatmentNot Availablecompleted
NCT01159951
Analysis of Trends Over Time of Hepatitis Related Incidence in PanamaNo drug interventionsNot AvailableNot Availablecompleted
NCT00224705
The MARS® Albumin Dialysis System in Patients With Fulminant and Subfulminant Hepatic FailureNo drug interventionstreatment3completed
NCT00059397
Hepatitis C: Grading and Staging by MRNo drug interventionsNot AvailableNot Availablecompleted
NCT02764671
Safety and Immunogenicity of Recombinant Hepatitis B Vaccines in the Neonatesprevention4unknown_status
NCT00039871
PEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to Alpha-Interferon Plus Ribavirin (Study P02370)treatment3completed
NCT03482388
Crowdsourcing to Promote HBV and HCV Testing in ChinaNo drug interventionsscreeningNot Availablecompleted
NCT00160407
Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH)treatment4completed
NCT00987337
Filibuvir In Treatment Naive Hepatitis C Virus (HCV) Genotype 1 Subjectstreatment2completed
NCT05414552
ECP for Immune-related Adverse Events After Checkpoint Inhibitor TreatmentNo drug interventionsNot AvailableNot Availablecompleted
NCT04618575
Ursodeoxycholic Acid Combined With Total Glucosides of Paeony in the Treatment of PBC With AIH Features 1treatment4unknown_status
NCT00564642
Investigation of the Effect of N Acetylcysteine Against Anti-Tuberculosis Drugs Induced Liver ToxicitypreventionNot Availablecompleted
NCT02075242
TO Compare the Triple Drug Therapy and Dual Therapy .treatment4unknown_status
NCT00080236
Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantationtreatment2completed
NCT00076336
Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosistreatment3completed
NCT02128217
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infectiontreatment1completed
NCT00901524
ANRS HC20 Effectiveness of an Optimized Anti HCV PegIFN-alpha2a + Ribavirin on Sustained Virological Response in Patients With HCV Genotype 1 and 4 Non Responders and Co-infected With HIVtreatment2completed
NCT01102296
Effectiveness of Hepatitis A Virus Vaccination Among Homosexual Males at Risk for Hepatitis A InfectionpreventionNot Availablecompleted
NCT00412763
Efficacy of Silymarin for Acute Hepatitistreatment4completed
NCT00929786
Anti-tuberculosis (TB) Drug Levels and HepatotoxicityNo drug interventionsNot AvailableNot Availablecompleted
NCT04306939
Genomic Resources for Enhancing Available Therapies (GREAT1.0) StudyNo drug interventionsNot AvailableNot Availablesuspended
NCT02103439
An Open-label Randomized Multicenter Phase III Clinical Study Comparing Safety and Efficacy of Algeron (Cepeginterferon Alfa-2b) and and PegIntron (Peginterferon Alfa-2b) in Combination With Ribavirin as Combined Treatment of Chronic Hepatitis C in Human Immunodeficiency Virus-1 Infected Patientstreatment3completed
NCT02368522
Comparative Assessment of Utilization of Antiviral Therapies in Hepatitis C and Effectiveness of Daclatasvir-containing Regimens in Real-life Clinical Care in Europe (CMPASS-EU)No drug interventionsNot AvailableNot Availablecompleted
NCT03119025
Autologous Dendritic Cell Vaccine for Treatment of Patients With Chronic HCV-InfectionNo drug interventionstreatment1 / 2completed
NCT05635266
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research InitiativesNo drug interventionsNot AvailableNot Availablerecruiting
NCT02920931
A Randomized, Open-label, Single-dosing, 2X2 Crossover Study to Compare the Safety and Pharmacokinetics of BR-TND Tablet(Tenofovir Disoproxil) With Viread Tablet(Tenofovir Disoproxil Fumarate) in Healthy Male Volunteerstreatment1completed
NCT01641276
Identification of Specific Modulation Frequencies in Hepatitis B Carriers With and Without Hepatocellular CarcinomaNo drug interventionsdiagnosticNot Availablecompleted
NCT01390194
Rapid 10-Minute Liver MRI Protocol in Patients With Suspected Hepatocellular CarcinomaNo drug interventionsNot AvailableNot Availablecompleted
NCT00194480
Treatment of Acute Hepatitis C Virus Infection With Pegylated Interferon in Injection Drug UsersNo drug interventionstreatment4completed
NCT05719480
A Bidirectional Study in Exploring the Dynamic Changes of Plasma and Urine Metabolites of Liver CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT06395129
Low Dead-space Injecting Equipment Distribution Program for People Who Inject Drugs in Low- and Middle-income CountriesNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00108589
S-Adenosylmethionine Therapy for Non-Alcoholic Steatohepatitistreatment3completed
NCT01740089
Algeron (Cepeginterferon Alfa-2b) Compared With PegIntron (Peginterferon Alfa-2b) for Treatment of Chronic Hepatitis Ctreatment2 / 3completed
NCT00679692
Evaluation the Growth Factors(IGF-1,IGFBP-3and HGH)in Patients With Chronic Liver DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT05062967
Evaluation of Orthohepevirus C Infection as an Emerging Cause of Zoonotic Origin DiseaseNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00088504
Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis Ctreatment2completed
NCT04757272
Does Hepatitis C Management Protect Egyptian Population Against Severe Corona Virus Disease-2019?No drug interventionsNot AvailableNot Availablecompleted
NCT00591968
Telesonography Adaptation and Use to Improve the Standard of Patient Care Within a Dominican CommunityNo drug interventionshealth_services_researchNot Availablecompleted
NCT00287469
A Safety and Efficacy Study of the Hepatitis E Vaccine in Nepal.No drug interventionsprevention2completed
NCT01434212
Patterns of Early Hepatitis C Virus Decline Predict the Outcome of Interferon TherapyNot AvailableNot Availableunknown_status
NCT00594412
MRI to Measure Liver Fat ContentNo drug interventionsdiagnosticNot Availablecompleted
NCT04846010
Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2No drug interventionstreatment1 / 2unknown_status
NCT06571981
Conventional Ultrasound Versus Remote Ultraportable ulTrasound in the Context of Viral HepatitisNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT05738681
Efficacy of N-acetylcysteine to Prevent Anti-tuberculosis Drug-induced Liver Injury: A Randomized Controlled Trialprevention2 / 3recruiting
NCT04593355
HCV Epidemiological Survey in China Rural AreaNo drug interventionsNot AvailableNot Availablecompleted
NCT01724723
Using Entecavir to Reduce Hepatitis in Highly Viremic HBV Patients During Anti-tuberculous Treatmentprevention4unknown_status
NCT02613403
Efficacy and Safety of Grazoprevir (+) Uprifosbuvir (+) Ruzasvir (MK-3682B) (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)treatment2terminated
NCT03619590
Twinrix Pregnancy RegistryNo drug interventionsNot AvailableNot Availablecompleted
NCT00062764
Treating Nonalcoholic Steatohepatitis With Pioglitazonetreatment2completed
NCT00815464
A Single-Arm Study Evaluating the Efficacy of Liquid Acupuncture Therapeutics in Chronic Hepatitis BNo drug interventionstreatmentNot Availableunknown_status
NCT00147784
HEPMET-1: Evaluate the Feasibility, Mental Sideeffects and the Efficacy of Hepatitis C Treatment in a MMT Group.treatment3completed
NCT00001879
Collections of Blood and Stool Samples in Patients With Acute HepatitisNo drug interventionsNot AvailableNot Availablecompleted
NCT06072287
The Living With a Long-Term Condition StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT01395654
Reintroduction Regimens After Hepatitis During Anti-tuberculosis Treatmenttreatment4unknown_status
NCT03410953
Vaccination Adjuved Against Hepatitis B in SNS Workers Typed as no Responders to Conventional Vaccinesprevention4completed
NCT01456845
Anti-tuberculosis (TB) Drug Levels and Correlation With Drug Induced HepatotoxicityNo drug interventionsNot AvailableNot Availablecompleted
NCT03692897
An Observational Study of Patients With Chronic Hepatitis B (CHB) InfectionNo drug interventionsNot AvailableNot Availablerecruiting
NCT05563961
A Partial Randomized, Single-blind or Open-label, Dose-escalation With Multiple-dose Design Study to Evaluate the Pharmacokinetics of Acetaminophen and Its Toxic Metabolites With Panadol® and SafeTynadol® in Healthy VolunteerspreventionNot Availablerecruiting
NCT03509688
The Curative Effect of Entecavir Combined Resveratrol on HBV patients-a Multi-center, Random, Open Clinical TrialtreatmentNot Availablecompleted
NCT00023309
Lamivudine and Adefovir to Treat Chronic Hepatitis Btreatment2completed
NCT00300209
Manhattan HIV/Hepatology Brain BankNo drug interventionsNot AvailableNot Availablecompleted
NCT01725815
The Health Access and Recovery Peer ProgramNo drug interventionstreatmentNot Availablecompleted
NCT00575315
HIV-HCV Coinfection: Impact of Immune DysfunctionNo drug interventionsNot AvailableNot Availablecompleted
NCT00063232
Treating Nonalcoholic Steatohepatitis (NASH) With Metformintreatment2completed
NCT06111859
Effectiveness of Ultrasound in Liver Stiffness and Fat QuantificationNo drug interventionsdiagnosticNot Availablerecruiting
NCT03085342
Evaluation of Hepatic Fibrosis on Multiparametric MRINo drug interventionsdiagnosticNot Availableunknown_status
NCT00465842
Protein Biomarker in Hepatocellular CarcinomaNo drug interventionsNot AvailableNot Availableterminated
NCT00141999
Response to Booster Doses of Hepatitis B Vaccine in Children and AdolescentsNot AvailableNot Availablecompleted
NCT00144313
VaxTeen Hepatitis B Vaccine Booster Studyprevention4completed
NCT04595734
Liver Toxicity in Lung Cancer Patients Treated With Immune-checkpoint Inhibitors.No drug interventionsNot AvailableNot Availablerecruiting
NCT02126696
Comorbidities and Virologic Outcome Among Patients on Anti-retroviral Therapy in Rural LesothoNo drug interventionsNot AvailableNot Availablecompleted
NCT05989958
The Safety and Tolerability Study of HepaCure in Chinese Subjects with Acute-On-Chronic Liver FailureNo drug interventionstreatment1recruiting
NCT00218335
A Network & Dyad HIV Prevention Intervention for IDU's - 1No drug interventionsprevention2completed
NCT01159925
Surveillance Study to Determine the Trends in Acute Hepatitis A Among Panamanian ChildrenNo drug interventionsNot AvailableNot Availablecompleted
NCT00004848
A Controlled Prospective Study of Transfusion-Associated HepatitisNo drug interventionsNot AvailableNot Availablecompleted
NCT05557448
To Evaluate the Efficacy and Safety of TYNADOTE® in the Treatment of Acetaminophen OverdoseNo drug interventionstreatment2recruiting
NCT01142882
Comparative Effectiveness of Web-based Versus Traditional Adolescent HIV PreventionNo drug interventionspreventionNot Availableunknown_status
NCT03776760
Strategies for Hepatitis C Testing and Treatment in Aboriginal Communities That Lead to EliminationNot AvailableNot Availableunknown_status
NCT05813691
Epidemiology of Occult Hepatitis C Virus Infection in Patients Born Before 1969 in the Hospital Setting: a Spontaneous Opportunistic Screening Initiative.No drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT03480529
Monitoring the IMmUological TOXicity of DrugsNo drug interventionsNot AvailableNot Availablecompleted
NCT01068444
The Efficacy and Safety of Pioglitazone in Patients With Nonalcoholic Steatohepatitistreatment2completed
NCT02108444
Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT01163240
Epidemiological Study in Children and Adolescents With Chronic Hepatitis BNo drug interventionsNot AvailableNot Availablecompleted
NCT02275195
Immune Cell Dysfunction in Severe Alcoholic HepatitisNo drug interventionsNot AvailableNot Availablerecruiting
NCT01443923
Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIVtreatment4terminated
NCT03685708
HEPLISAV-B Hepatitis B Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's-Tyrosine Kinase Inhibitor (BTK-I)prevention2completed